Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hepatocyte nuclear transcription machinery refers to a complex, interconnected network of transcription factors and co-regulators that govern the liver-specific gene expression program (Odom et al., 2004). This machinery is primarily composed of the hepatocyte nuclear factors (HNFs), including HNF1α, HNF1β, HNF3 (FOXA1/2/3), HNF4α, and HNF6, which operate in a hierarchical and cross-regulatory manner to maintain hepatocyte identity and function (Kyrmizi et al., 2006; Lau et al., 2018). It plays a central role in regulating essential physiological processes such as glucose and lipid metabolism, bile acid synthesis, and the production of plasma proteins like albumin (Hayhurst et al., 2001). Dysregulation of this transcriptional network is a hallmark of various metabolic disorders, such as Maturity-Onset Diabetes of the Young (MODY), and chronic liver diseases, including non-alcoholic fatty liver disease (NAFLD) and hepatocellular carcinoma (Boj et al., 2001; Yuan et al., 2009). While the machinery as a whole is a biological system rather than a single therapeutic target, individual components like HNF4α are actively pursued as targets for their ability to reprogram liver metabolism and inhibit cancer progression (Kiselyuk et al., 2012; Bogan et al., 2007).
Modulation of the transcriptional activity of liver-specific factors, particularly HNF4A, to restore metabolic homeostasis or suppress oncogenic gene expression programs.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatocyte nuclear transcription machinery.